GET DAILY SIGNALSBanco Macro (BMA) Declines -14.5% Over the Past 30 Days Amid Regional Headwinds
Key Takeaways
- Banco Macro shares have declined roughly 14.5% over the past 30 days, falling from about $68.86 to near $58.90, extending a broader multi-month downtrend.
- The selloff accelerated in late October after an unexpected outcome in Brazil's presidential election triggered a sharp regional risk-off across Argentine ADRs.
- Second-quarter 2026 results showed improved profitability, but management lowered its 2026 loan-growth guidance, citing subdued credit demand and rising delinquencies.
- UBS cut its price target on the stock to $90 from $130 in mid-October while maintaining a Buy rating, reflecting reduced near-term confidence.
- Over the trailing quarter, the shares are down roughly 34%, weighed down by credit normalization, election uncertainty, and weaker operating momentum.
- For additional detail on the company, explore dedicated pages for Price Targets, Earnings, and Forecast.
- Investors tracking systematic strategies can also explore Trending AI Robots for curated, algorithm-driven trading ideas.
Banco Macro (BMA) Company Snapshot and Market Position
Banco Macro S.A. operates as a universal Argentine bank and stands out as the private local lender with the largest branch network in the country. Based in Buenos Aires, it focuses on low- and middle-income individuals along with small and mid-sized companies through its extensive national presence. As of the second quarter of 2026, the bank ran 402 branches with roughly 8,180 employees, serving about 6.36 million retail customers across 23 of Argentina's 24 provinces and more than 228,000 corporate clients.
Its foundation comes from a low-cost, transaction-oriented deposit base that made up about 76% of total liabilities, paired with strong balance-sheet metrics. The Tier 1 capital ratio sat near 28%, liquid assets reached roughly 74% of deposits, and the bank held an 8.2% share of the private-sector loan market. I often view BMA as a useful proxy for tracking Argentina's consumer banking recovery and the broader macroeconomic and credit cycle.
Banco Macro (BMA) Stock Price Moves: Last 30 Days Compared to the Quarter
Over the last 30 days, BMA declined approximately 14.5%, shifting from a closing level near $68.86 in late September to about $58.90 in late October. The decline unfolded gradually rather than in one sharp session, though it included steeper single-day drops toward the end of the period. I checked comparable moves using Tickeron’s AI Screener to see how the stock stacked up against peers in the region.
The quarterly view shows even more pressure. About three months earlier the stock traded near $89, so it has given up approximately 34% over that span. This fits into a longer slide that started after the shares peaked around the low $100s in mid-2026. The ongoing downtrend stems from softening credit growth, asset-quality pressures, and rising political and macro uncertainty in Argentina and the wider region.
Factors Behind the 30-Day Decline
The clearest near-term trigger came from outside the company. An unexpected result in Brazil's presidential runoff election in late October sparked a broad selloff in Brazilian assets that quickly spread to Argentine equities. In premarket trading, BMA traded down several percentage points alongside peers such as GGAL and YPF, as investors reassessed regional fiscal and political risk.
Company-specific elements added to the pressure. When Banco Macro reported second-quarter 2026 results in August, net income rose 39% quarter-over-quarter to ARS 206.8 billion, and adjusted return on equity reached 14.3%. At the same time, management reduced its loan-growth guidance for the year because of weaker credit demand and rising delinquencies. The non-performing loan ratio climbed to 6.25% from 5.40% in the prior quarter, with consumer NPLs continuing to rise even though the bank's asset quality stayed better than the system average.
Analyst moves also influenced sentiment. In mid-October, UBS lowered its price target to $90 from $130 while keeping a Buy rating, which pointed to lower near-term conviction. Together with normalizing credit conditions and Argentina's pre-electoral backdrop, these elements sustained selling pressure through the month.
Quarterly Performance Pressures
The quarterly drop reflects a broader change in the investment story around Argentine banks. After strong loan growth and better profitability, the sector moved into a phase of credit normalization. Banco Macro's lending growth slowed noticeably, and management signaled more modest expansion for 2026, indicating that the favorable financing environment of earlier years was easing.
Asset-quality concerns also gained attention. Although the bank's capital and liquidity stayed solid, rising non-performing loans and lower coverage ratios led investors to reprice risk. Regional political uncertainty, including Brazil's election outcome and Argentina's own pre-electoral setting, added volatility. The result was a de-rating that erased much of the stock's earlier gains, even while underlying earnings held up.
What to Watch Next for BMA Stock
Looking ahead, investors will track the path of Argentina's credit cycle and Banco Macro's progress in stabilizing loan growth while handling non-performing loans. Upcoming earnings will draw attention for updated guidance on lending, net interest margin, and asset quality, especially whether consumer delinquency trends start to level off.
Macroeconomic and political developments will stay important. Inflation, interest rates, and peso exchange-rate shifts directly affect the bank's net interest income and funding costs, while Argentina's pre-electoral calendar and regional dynamics, including moves in Brazil, could keep volatility high. Analyst revisions and any shifts in capital-return plans offer additional signals. These remain factors to monitor rather than a basis for any specific investment decision.
Using Tickeron AI Tools for Deeper Analysis
In my research process, I frequently turn to Tickeron’s AI tools to cross-check patterns and compare performance across similar names. One platform I find particularly useful helps surface systematic, algorithm-driven ideas that align with different risk tolerances and timeframes, giving a practical way to filter through market noise when evaluating names like BMA.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BMA's RSI Indicator recovers from oversold territory
The RSI Oscillator for BMA moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 25 of the 28 cases the stock moved higher. This puts the odds of a move higher at 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 56 cases where BMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on BMA as a result. In 72 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for BMA just turned positive on October 13, 2026. Looking at past instances where BMA's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.
Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMA advanced for three days, in 235 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for BMA moved below the 200-day moving average on September 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for BMA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.271). P/E Ratio (0.001) is within average values for comparable stocks, (13.247). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.190). Dividend Yield (0.029) settles around the average of (0.035) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.738).
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a regional bank
Industry RegionalBanks
Advertisement